KEQUNasdaqLaboratory Apparatus & FurnitureFiscal year ends April 30
KEWAUNEE SCIENTIFIC CORP /DE/
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026
$32.10−0.82 (-2.51%)
Close on Oct 19, 2026
- Market cap
- $93.76M
- P/E (TTM)
- 11.6
- Dividend yield
- –
Share price
−$11.09 (−25.68%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
KEWAUNEE SCIENTIFIC CORP /DE/ grew revenue 5.3% to $277.22M over the twelve months to Jul 31, 2026. Operating income fell 24.7% to $15.06M, moving the operating margin from 7.6% to 5.4%. Free cash flow was $10.88M, down 41.8% from a year earlier.
Revenue
$277.22M
+5.3% vs. a year earlier
Operating income
$15.06M
-24.7% vs. a year earlier
Free cash flow
$10.88M
-41.8% vs. a year earlier
EPS, diluted
$2.76
-33.2% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $93.76M
- P/E ratio
- 11.6
- Price to sales
- 0.34
- Price to book
- 1.25
- Dividend yield
- –
- Free cash flow yield
- 11.60%
Fundamentals
- Revenue
- $277.22M
- Net income
- $8.23M
- EPS, diluted
- $2.76
- Free cash flow
- $10.88M
- Book value per share
- $25.68
- Diluted shares
- 3M
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
$277.22M+5.3% YoY
Gross profit
$79.15M+2.4% YoY
Operating income
$15.06M-24.7% YoY
Net income
$8.23M-33.1% YoY
EPS, diluted
$2.76-33.2% YoY
Free cash flow
$10.88M-41.8% YoY
Reported periodTrailing twelve months